The biotech sector, from a technical perspective, indeed presents an opportunity for increased positions on the left side. But it depends on your own mindset—if you're risk-averse, you can follow the approach from the previous two times: wait until the decline is sufficient and the rebound begins before entering the market. This way, you avoid eating the top or the bottom, and you'll feel much more comfortable.
If you think you can earn a little more on the left side, then consider opening and adding to your positions in batches. Follow the rhythm of "buying one layer after a two-layer decline," rolling through 3 to 5 layers, which is enough—there's no need to go all-in at once. This way, you can participate in opportunities without risking too much by going all-in. The key is to operate according to your own risk tolerance and avoid blindly following the trend.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
12 Likes
Reward
12
6
Repost
Share
Comment
0/400
TooScaredToSell
· 6h ago
Waiting for the rebound before jumping in is indeed safer, but it's easy to miss those few days of rapid surge.
View OriginalReply0
MemecoinTrader
· 6h ago
ngl the "wait for bounce day one" psyops is just peak risk aversion theater... but yeah sentiment analysis shows biotech left side accumulation is *chef's kiss* for narrative positioning rn. the real alpha? nobody's talking about the memetic velocity shift when retail starts doomscrolling the dip. watch how this cascades.
Reply0
BearMarketMonk
· 6h ago
Ah, this is the classic "if you're afraid of death, don't play; if you want to make money, stratify" routine... Adding positions on the biotech side? The cycle hasn't truly arrived yet, and they're already thinking about the first day of rebound. So many people just miss the boat with perfect precision.
View OriginalReply0
WenMoon
· 6h ago
The opportunities on the biotech side are pretty good, just worried that my hands might get itchy again, haha.
View OriginalReply0
DaoTherapy
· 7h ago
Biotechnology this wave on the left side is indeed tempting, but I still stick to my words — mindset comes first, don't be greedy.
View OriginalReply0
PerennialLeek
· 7h ago
The left-side opportunity in biotech is indeed there, but to be honest, I'm still a bit hesitant. I'd rather wait for a rebound confirmation before jumping in.
The biotech sector, from a technical perspective, indeed presents an opportunity for increased positions on the left side. But it depends on your own mindset—if you're risk-averse, you can follow the approach from the previous two times: wait until the decline is sufficient and the rebound begins before entering the market. This way, you avoid eating the top or the bottom, and you'll feel much more comfortable.
If you think you can earn a little more on the left side, then consider opening and adding to your positions in batches. Follow the rhythm of "buying one layer after a two-layer decline," rolling through 3 to 5 layers, which is enough—there's no need to go all-in at once. This way, you can participate in opportunities without risking too much by going all-in. The key is to operate according to your own risk tolerance and avoid blindly following the trend.